IL17C and psoriasis: Considering that almost all IL-17 cytokines (notably IL-17A, IL-17F, IL-17C, and IL-17E) have been shown to play some role in psoriasis pathogenesis, an approach based on receptor blockade, rather than cytokine inhibition, provides a consistent and valuable treatment strategy [27].